232 related articles for article (PubMed ID: 9931208)
1. Cerebral vasomotor reactivity at high altitude in humans.
Jansen GF; Krins A; Basnyat B
J Appl Physiol (1985); 1999 Feb; 86(2):681-6. PubMed ID: 9931208
[TBL] [Abstract][Full Text] [Related]
2. Changes in cerebral blood flow and vasoreactivity to CO2 measured by arterial spin labeling after 6days at 4350m.
Villien M; Bouzat P; Rupp T; Robach P; Lamalle L; Troprès I; Estève F; Krainik A; Lévy P; Warnking JM; Verges S
Neuroimage; 2013 May; 72():272-9. PubMed ID: 23384523
[TBL] [Abstract][Full Text] [Related]
3. Evidence from high-altitude acclimatization for an integrated cerebrovascular and ventilatory hypercapnic response but different responses to hypoxia.
Smith ZM; Krizay E; Sá RC; Li ET; Scadeng M; Powell FL; Dubowitz DJ
J Appl Physiol (1985); 2017 Dec; 123(6):1477-1486. PubMed ID: 28705997
[TBL] [Abstract][Full Text] [Related]
4. Effects of high altitude exposure on cerebral hemodynamics in normal subjects.
Van Osta A; Moraine JJ; Mélot C; Mairbäurl H; Maggiorini M; Naeije R
Stroke; 2005 Mar; 36(3):557-60. PubMed ID: 15692117
[TBL] [Abstract][Full Text] [Related]
5. Augmented hypoxic cerebral vasodilation in men during 5 days at 3,810 m altitude.
Jensen JB; Sperling B; Severinghaus JW; Lassen NA
J Appl Physiol (1985); 1996 Apr; 80(4):1214-8. PubMed ID: 8926248
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of residence at moderate versus low altitude on reducing acute mountain sickness in men following rapid ascent to 4300 m.
Staab JE; Beidleman BA; Muza SR; Fulco CS; Rock PB; Cymerman A
High Alt Med Biol; 2013 Mar; 14(1):13-8. PubMed ID: 23537255
[TBL] [Abstract][Full Text] [Related]
7. UBC-Nepal expedition: markedly lower cerebral blood flow in high-altitude Sherpa children compared with children residing at sea level.
Flück D; Morris LE; Niroula S; Tallon CM; Sherpa KT; Stembridge M; Ainslie PN; McManus AM
J Appl Physiol (1985); 2017 Oct; 123(4):1003-1010. PubMed ID: 28572497
[TBL] [Abstract][Full Text] [Related]
8. Right temporal cerebral dysfunction heralds symptoms of acute mountain sickness.
Feddersen B; Ausserer H; Neupane P; Thanbichler F; Depaulis A; Waanders R; Noachtar S
J Neurol; 2007 Mar; 254(3):359-63. PubMed ID: 17345040
[TBL] [Abstract][Full Text] [Related]
9. Postural ataxia at high altitude is not related to mild to moderate acute mountain sickness.
Baumgartner RW; Eichenberger U; Bärtsch P
Eur J Appl Physiol; 2002 Feb; 86(4):322-6. PubMed ID: 11990745
[TBL] [Abstract][Full Text] [Related]
10. Cerebral blood flow at high altitude.
Ainslie PN; Subudhi AW
High Alt Med Biol; 2014 Jun; 15(2):133-40. PubMed ID: 24971767
[TBL] [Abstract][Full Text] [Related]
11. UBC-Nepal expedition: The use of oral antioxidants does not alter cerebrovascular function at sea level or high altitude.
Hansen AB; Hoiland RL; Lewis NCS; Tymko MM; Tremblay JC; Stembridge M; Nowak-Flück D; Carter HH; Bailey DM; Ainslie PN
Exp Physiol; 2018 Apr; 103(4):523-534. PubMed ID: 29427527
[TBL] [Abstract][Full Text] [Related]
12. Cerebral autoregulation in subjects adapted and not adapted to high altitude.
Jansen GF; Krins A; Basnyat B; Bosch A; Odoom JA
Stroke; 2000 Oct; 31(10):2314-8. PubMed ID: 11022056
[TBL] [Abstract][Full Text] [Related]
13. Fluid retention and relative hypoventilation in acute mountain sickness.
Hackett PH; Rennie D; Hofmeister SE; Grover RF; Grover EB; Reeves JT
Respiration; 1982; 43(5):321-9. PubMed ID: 6815746
[TBL] [Abstract][Full Text] [Related]
14. Symptoms of acute mountain sickness in Sherpas exposed to extremely high altitude.
Droma Y; Hanaoka M; Basnyat B; Arjyal A; Neupane P; Pandit A; Sharma D; Kubo K
High Alt Med Biol; 2006; 7(4):312-4. PubMed ID: 17173517
[TBL] [Abstract][Full Text] [Related]
15. Alterations in cerebral dynamics at high altitude following partial acclimatization in humans: wakefulness and sleep.
Ainslie PN; Burgess K; Subedi P; Burgess KR
J Appl Physiol (1985); 2007 Feb; 102(2):658-64. PubMed ID: 17053102
[TBL] [Abstract][Full Text] [Related]
16. Acute mountain sickness is associated with sleep desaturation at high altitude.
Burgess KR; Johnson P; Edwards N; Cooper J
Respirology; 2004 Nov; 9(4):485-92. PubMed ID: 15612960
[TBL] [Abstract][Full Text] [Related]
17. Intermittent altitude exposures reduce acute mountain sickness at 4300 m.
Beidleman BA; Muza SR; Fulco CS; Cymerman A; Ditzler D; Stulz D; Staab JE; Skrinar GS; Lewis SF; Sawka MN
Clin Sci (Lond); 2004 Mar; 106(3):321-8. PubMed ID: 14561214
[TBL] [Abstract][Full Text] [Related]
18. The effect of altitude pre-acclimatization on acute mountain sickness during reexposure.
Lyons TP; Muza SR; Rock PB; Cymerman A
Aviat Space Environ Med; 1995 Oct; 66(10):957-62. PubMed ID: 8526832
[TBL] [Abstract][Full Text] [Related]
19. Increase of cerebral blood flow at high altitude: its possible relation to AMS.
Lassen NA
Int J Sports Med; 1992 Oct; 13 Suppl 1():S47-8. PubMed ID: 1483789
[TBL] [Abstract][Full Text] [Related]
20. Cerebrovascular reactivity is increased with acclimatization to 3,454 m altitude.
Flück D; Siebenmann C; Keiser S; Cathomen A; Lundby C
J Cereb Blood Flow Metab; 2015 Aug; 35(8):1323-30. PubMed ID: 25806704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
